作者:
DaCruz,F.P. [1]
;
Martin,C. [2]
;
Buchholz,K. [3]
;
Lafuente-Monasterio,M.J. [4]
;
Rodrigues,T. [5]
;
S?nnichsen,B. [6]
;
Moreira,R. ;
Gamo,F.-J. ;
Marti,M. ;
Mota,M.M. ;
Hannus,M. ;
Prudêncio,M.
作者单位:
Cenix BioScience GmbH, Dresden, Germany
[1]
Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Av. Prof. Egas
[2]
Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich
[3]
Tres Cantos Medicine Development Campus, Diseases of the Developing World, GlaxoSmithKline, Tres
[4]
IMed.UL, Faculdade de Farmácia, Universidade de Lisboa, Portugal
[5]
Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA
[6]
发布时间
2013-11-20